SFRP2 and plasma cell myeloma: Thus, in vitro suppression of the mineralization and alkaline phosphatase activity of osteoblasts has been correlated with sFRP-2 secretion in myeloma cell lines and primary myeloma cells from patients with advanced bone lesions [38].